JP2012515170A5 - - Google Patents

Download PDF

Info

Publication number
JP2012515170A5
JP2012515170A5 JP2011545542A JP2011545542A JP2012515170A5 JP 2012515170 A5 JP2012515170 A5 JP 2012515170A5 JP 2011545542 A JP2011545542 A JP 2011545542A JP 2011545542 A JP2011545542 A JP 2011545542A JP 2012515170 A5 JP2012515170 A5 JP 2012515170A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
prg4
androgen
vaginal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011545542A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012515170A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/020929 external-priority patent/WO2010083239A2/en
Publication of JP2012515170A publication Critical patent/JP2012515170A/ja
Publication of JP2012515170A5 publication Critical patent/JP2012515170A5/ja
Pending legal-status Critical Current

Links

JP2011545542A 2009-01-13 2010-01-13 膣上皮境界潤滑の治療的調節 Pending JP2012515170A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14434409P 2009-01-13 2009-01-13
US61/144,344 2009-01-13
US26040209P 2009-11-12 2009-11-12
US61/260,402 2009-11-12
PCT/US2010/020929 WO2010083239A2 (en) 2009-01-13 2010-01-13 Therapeutic modulation of vaginal epithelium boundary lubrication

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015062261A Division JP6039723B2 (ja) 2009-01-13 2015-03-25 膣上皮境界潤滑の治療的調節

Publications (2)

Publication Number Publication Date
JP2012515170A JP2012515170A (ja) 2012-07-05
JP2012515170A5 true JP2012515170A5 (enExample) 2012-09-13

Family

ID=42340279

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011545542A Pending JP2012515170A (ja) 2009-01-13 2010-01-13 膣上皮境界潤滑の治療的調節
JP2015062261A Expired - Fee Related JP6039723B2 (ja) 2009-01-13 2015-03-25 膣上皮境界潤滑の治療的調節

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015062261A Expired - Fee Related JP6039723B2 (ja) 2009-01-13 2015-03-25 膣上皮境界潤滑の治療的調節

Country Status (7)

Country Link
US (1) US8980840B2 (enExample)
EP (1) EP2381957B1 (enExample)
JP (2) JP2012515170A (enExample)
CN (1) CN102438645A (enExample)
CA (1) CA2749480C (enExample)
ES (1) ES2534082T3 (enExample)
WO (1) WO2010083239A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5449775B2 (ja) 2005-10-19 2014-03-19 チャバフ ピーティーワイ エルティーディー 乳癌の治療に使用されるアロマターゼ阻害薬による副作用の低減
EP2381957B1 (en) * 2009-01-13 2015-01-07 Lubris LLC Therapeutic modulation of vaginal epithelium boundary lubrication
CA3110817C (en) * 2009-05-22 2023-08-15 Lubris, Llc Application and uses of prg4 and therapeutic modulation thereof
US9107885B2 (en) * 2009-08-13 2015-08-18 Lubris Llc PRG4 treatment for interstitial cystitis
CN102552996A (zh) * 2010-12-07 2012-07-11 宁小静 人体润滑剂
ES2395801B1 (es) * 2011-06-23 2014-06-06 María Carmen PARDINA PALLEJÀ "pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015060935A1 (en) 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
EP4062924A1 (en) 2013-11-26 2022-09-28 Lubris LLC Compositions and methods for inhibiting intercellular interactions
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
EP3174542A4 (en) 2014-07-29 2018-01-03 TherapeuticsMD, Inc. Transdermal cream
EP3209301B1 (en) 2014-10-22 2023-06-07 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
RU2017129880A (ru) * 2015-01-26 2019-03-04 ЛУБРИС ЭлЭлСи Применение prg4 в качестве противовоспалительного средства
JP7291459B2 (ja) 2015-05-19 2023-06-15 ルブリス，エルエルシー． 動体視力および高次収差を改善するためのｐｒｇ４の使用
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3364978A4 (en) 2015-10-22 2019-06-05 Havah Therapeutics Pty Ltd METHOD FOR REDUCING MAMMOGRAPHIC BREAST DENSITY AND / OR BREAST CANCER RISK
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3142193A1 (en) 2019-06-03 2020-12-10 Havah Therapeutics Pty Ltd Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor and methods for use
WO2023042216A1 (en) * 2021-09-15 2023-03-23 Chemex Global Topical pharmaceutical compositions for treatment of infertility
CN118976097B (zh) * 2024-10-22 2025-01-24 北京岷德生物科技有限公司 一种治疗妇科疾病的组合物及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005A (en) * 1843-03-17 Power-loom
US7000A (en) * 1850-01-08 Smut-machine
US7027A (en) * 1850-01-15 Circulak
US5326558A (en) 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
AU740758B2 (en) * 1997-10-28 2001-11-15 Vivus, Inc. Treatment of female sexual dysfunction
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US20030059489A1 (en) * 2001-09-24 2003-03-27 Canolio Inc. Genital lubricating compositions and uses thereof
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US20060240037A1 (en) * 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
UA91818C2 (ru) 2003-08-14 2010-09-10 Уайт Рекомбинантные молекулы лубрицина и их использование
EP1727802A1 (en) * 2004-02-25 2006-12-06 Smithkline Beecham Corporation Substituted quinoline compounds for use as selective estrogen receptor modulator
EP1740190A1 (de) * 2004-03-05 2007-01-10 Synthes GmbH Verwendung eines gemisches für die herstellung eines mittels zur behandlung von defektem oder degeneriertem knorpel in vivo und bei der herstellung von natürlichem knorpelersatz in vitro
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US10016442B2 (en) * 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
WO2007070067A1 (en) * 2005-12-16 2007-06-21 Lyle Corporate Development, Inc. Regeneration of vaginal tissue with non-systemic vaginal administration of estrogen
US20070264309A1 (en) * 2006-01-20 2007-11-15 Chollet Janet A Method Of Treating Atrophic Vaginitis
WO2008133928A2 (en) * 2007-04-27 2008-11-06 The Gi Company, Inc. Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
WO2008143816A1 (en) * 2007-05-15 2008-11-27 Mucosal Therapeutics Compositions and methods for reducing friction between the surface of tendons or other soft tissues
GB0722507D0 (en) * 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
EP2381957B1 (en) * 2009-01-13 2015-01-07 Lubris LLC Therapeutic modulation of vaginal epithelium boundary lubrication

Similar Documents

Publication Publication Date Title
CA2749480A1 (en) Therapeutic modulation of vaginal epithelium boundary lubrication
ES2586122T3 (es) Formulaciones de testosterona
CN100349572C (zh) 提高妇女睾酮和相关类固醇浓度的方法
JP2023002662A5 (enExample)
ES2641613T3 (es) Gel transdérmico de Nestorone®/Estradiol
US20160136231A1 (en) Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
US20110086825A1 (en) Therapeutic vaginal emollient
ES2338782T3 (es) Composicion farmaceutica oral que comprende 15-hidroxitestosterona y derivados.
TWI746613B (zh) 子宮內膜病症治療劑之用法及用量
EP2283865A1 (en) Method of increasing testosterone and related steroid concentrations in women
JP2013542190A5 (enExample)
KR20110045004A (ko) 충혈제거제 및 코르티코스테로이드를 포함하는 비강내 조성물
JP2015528501A5 (enExample)
US12357655B2 (en) Polyglutamic acid compositions and methods of using
JP2020500864A5 (enExample)
JP2023503373A (ja) 新規多機能オリゴペプチド
JP2017514851A5 (enExample)
CN1376070A (zh) 用于治疗子宫内膜组织子宫外增生、慢性骨盆疼痛和输卵管梗阻的方法
ES2932076T3 (es) Moduladores agonistas de los receptores de glucocorticoides selectivos (SEGRAM) no esteroideos y usos de los mismos
JP2018108993A (ja) 注腸剤
WO2016028903A1 (en) Oral transmucosal pharmaceutical compositions including testosterone and a c-sperm
WO2016028900A1 (en) Oral transmucosal pharmaceutical compositions including testosterone and an aromatase inhibitor
ITMI20121917A1 (it) Composizioni per uso vaginale comprendenti polisaccaridi da tamarindo
US20160051496A1 (en) Oral Transmucosal Compositions Including C-SERMs for Treating Female Infertility
WO2016028891A1 (en) ORAL TRANSMUCOSAL COMPOSITIONS INCLUDING C-SERMs FOR LOW TESTOSTERONE LEVELS IN MEN